Net Cash Provided by (Used in) Operating Activities |
3.07M |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
30K |
USD |
-0.7% |
Mar 31, 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Investing Activities |
-3.49M |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-419K |
USD |
-60.4% |
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
478K |
USD |
-65.2% |
Mar 31, 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
413K |
USD |
+40.9% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2023 |
Q1 2023 |
Deferred Tax Assets, Gross |
501K |
USD |
+5.36% |
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-206K |
USD |
+0.69% |
Dec 31, 2022 |
2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Mar 31, 2023 |
Q1 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Current Federal Tax Expense (Benefit) |
934K |
USD |
|
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2023 |
Q1 2023 |